Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Mind Medicine Mindmed Inc (MNMD)

Mind Medicine Mindmed Inc (MNMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 328,730
  • Shares Outstanding, K 421,449
  • Annual Sales, $ 0 K
  • Annual Income, $ -93,040 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.04
Trade MNMD with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.19
  • Most Recent Earnings -0.04 on 03/28/22
  • Next Earnings Date 05/16/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 161.45% ( -13.30%)
  • Historical Volatility 64.31%
  • IV Percentile 84%
  • IV Rank 44.87%
  • IV High 258.30% on 01/25/22
  • IV Low 82.63% on 09/27/21
  • Put/Call Vol Ratio 0.25
  • Today's Volume 2,209
  • Volume Avg (30-Day) 1,704
  • Put/Call OI Ratio 0.14
  • Today's Open Interest 164,716
  • Open Int (30-Day) 157,573

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/22
See More
  • Average Estimate -0.05
  • Number of Estimates 2
  • High Estimate -0.04
  • Low Estimate -0.06
  • Prior Year -0.04
  • Growth Rate Est. (year over year) -25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7010 +11.27%
on 05/12/22
1.0100 -22.77%
on 04/14/22
-0.2300 (-22.77%)
since 04/13/22
3-Month
0.7010 +11.27%
on 05/12/22
1.4100 -44.68%
on 02/16/22
-0.4700 (-37.60%)
since 02/11/22
52-Week
0.7010 +11.27%
on 05/12/22
4.0400 -80.69%
on 06/11/21
-2.2100 (-73.91%)
since 05/13/21

Most Recent Stories

More News
Why Earnings Season Could Be Great for Mind Medicine (MNMD)

Mind Medicine (MNMD) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

MNMD : 0.7800 (+6.05%)
Oregon to Become the First State to Legally Roll Out Psilocybin

FN Media Group Presents Microsmallcap.com Market Commentary   New York, NY – April 28, 2022 – Oregon is set to become the first US state to market legal psilocybin, the psychoactive substance found...

CYBN.NE : 0.520 (-3.70%)
MMED.NE : 1.020 (+4.08%)
CYBN : 0.4110 (-2.12%)
MNMD : 0.7800 (+6.05%)
CMPS : 7.63 (+8.07%)
JNJ : 176.85 (-0.57%)
SEEL : 0.5635 (+10.04%)
Why Psychedelics Could Soon Replace Antidepressants

FN Media Group Presents Microsmallcap.com Market Commentary   New York, NY – April 13, 2022 – Anxiety disorders are the most common mental illness in the US, affecting approximately 40 million adults...

CYBN.NE : 0.520 (-3.70%)
MMED.NE : 1.020 (+4.08%)
MYCO.NE : 1.250 (-2.34%)
SEEL : 0.5635 (+10.04%)
MNMD : 0.7800 (+6.05%)
CMPS : 7.63 (+8.07%)
MYCOF : 0.0410 (+46.43%)
CYBN : 0.4110 (-2.12%)
3 Psychedelic Stocks to Buy for Oregon’s Magic Mushroom Bill

These psychedelic stocks could gain as the market for mind-altering therapies emerges

MNMD : 0.7800 (+6.05%)
CYBN : 0.4110 (-2.12%)
FTRP : 0.9430 (+20.93%)
Demand for Toad Venom Rises Along With the Booming Psychedelics Market

FN Media Group Presents Microsmallcap.com Market Commentary   New York, NY – March 30, 2022 –  Depression and anxiety affect millions around the world and the venom of a toad is the latest  psychedelic...

MMED.NE : 1.020 (+4.08%)
MYCO.NE : 1.250 (-2.34%)
NUMI.TO : 0.3600 (+12.50%)
NUMIF : 0.2800 (+15.46%)
SEEL : 0.5635 (+10.04%)
MNMD : 0.7800 (+6.05%)
MYCOF : 0.0410 (+46.43%)
CMPS : 7.63 (+8.07%)
This Could be Game-Changing News for Millions Struggling with Obesity

The world may be a step closer to successfully treating obesity with psilocybin. That's because psilocybin activates serotonin receptors, or "nature's own appetite suppressant," as noted by Psychology...

NEON.CN : 0.080 (+14.29%)
NMDBF : 0.0631 (+6.95%)
CMPS : 7.63 (+8.07%)
CYBN : 0.4110 (-2.12%)
FTRP.TO : 1.20 (+18.81%)
FTRP : 0.9430 (+20.93%)
MNMD : 0.7800 (+6.05%)
One Step Closer to Treating the Global Obesity Epidemic

NeonMind Biosciences (CSE: NEON) (OTC: NMDBF) is another step closer to treating the global obesity epidemic. At the moment, worldwide obesity has tripled since 1975, says the World Health Organization....

NEON.CN : 0.080 (+14.29%)
NMDBF : 0.0631 (+6.95%)
CMPS : 7.63 (+8.07%)
CYBN : 0.4110 (-2.12%)
FTRP.TO : 1.20 (+18.81%)
FTRP : 0.9430 (+20.93%)
MNMD : 0.7800 (+6.05%)
Fighting Back Against the Mental Health Crisis with Outside-the-Box Thinking and Therapeutics

USA News Group – Before the global health crisis began at the beginning of 2020, 1 in 5 adults were receiving mental health treatment. As society emerges from the last two and a half years of disruptions,...

MOOD.CN : 0.100 (unch)
GHRS : 9.77 (+1.45%)
MNMD : 0.7800 (+6.05%)
CYBN : 0.4110 (-2.12%)
JNJ : 176.85 (-0.57%)
The World May be One Step Closer to Treating the Obesity Epidemic

NeonMind Biosciences (CSE:NEON)(OTC:NMDBF) is a step closer to bringing innovative psychedelic-based treatments to people suffering from obesity and mental health disorders. With obesity, for example,...

NEON.CN : 0.080 (+14.29%)
NMDBF : 0.0631 (+6.95%)
CMPS : 7.63 (+8.07%)
CYBN : 0.4110 (-2.12%)
FTRP.TO : 1.20 (+18.81%)
FTRP : 0.9430 (+20.93%)
MNMD : 0.7800 (+6.05%)
These Top Companies are Racing to Help Millions Struggling with Mental Health

Mental health is on the decline all over the world. In the U.S. for example, the White House noted, “Our country faces an unprecedented mental health crisis among people of all ages. Two out of five...

NEON.CN : 0.080 (+14.29%)
NMDBF : 0.0631 (+6.95%)
CMPS : 7.63 (+8.07%)
CYBN : 0.4110 (-2.12%)
FTRP.TO : 1.20 (+18.81%)
FTRP : 0.9430 (+20.93%)
MNMD : 0.7800 (+6.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Mind Medicine Inc. is a clinical-stage psychedelic medicine biotech company. It discovers, develops and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. Mind Medicine Inc. is based in New York, United States.

See More

Key Turning Points

3rd Resistance Point 0.8230
2nd Resistance Point 0.8090
1st Resistance Point 0.7945
Last Price 0.7800
1st Support Level 0.7660
2nd Support Level 0.7520
3rd Support Level 0.7375

See More

52-Week High 4.0400
Fibonacci 61.8% 2.7645
Fibonacci 50% 2.3705
Fibonacci 38.2% 1.9765
Last Price 0.7800
52-Week Low 0.7010

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar